Septerna

Performance

About Septerna

Septerna is a biotechnology company that discovers and advances novel small molecule medicines targeting G protein-coupled receptors (GPCRs). Based in South San Francisco, the company leverages its proprietary Native Complex Platform to drug GPCRs that are traditionally difficult to target, with a pipeline of oral small molecule candidates across multiple therapeutic areas. Septerna emphasizes a world-class team of GPCR experts and drug developers, pursuing innovative approaches to bring medicines to patients in endocrinology, immunology and inflammation, and metabolic diseases.